C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors Invests $2.54 Million in Chemed Co. (NYSE:CHE)

C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors acquired a new position in Chemed Co. (NYSE:CHE - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 4,794 shares of the company's stock, valued at approximately $2,540,000.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in CHE. CWM LLC increased its stake in shares of Chemed by 22.2% in the third quarter. CWM LLC now owns 485 shares of the company's stock worth $291,000 after acquiring an additional 88 shares during the period. Exchange Traded Concepts LLC increased its stake in shares of Chemed by 28.9% in the third quarter. Exchange Traded Concepts LLC now owns 1,537 shares of the company's stock worth $924,000 after acquiring an additional 345 shares during the period. Creative Planning increased its stake in shares of Chemed by 57.3% in the third quarter. Creative Planning now owns 1,932 shares of the company's stock worth $1,161,000 after acquiring an additional 704 shares during the period. NBC Securities Inc. increased its stake in shares of Chemed by 21.6% in the third quarter. NBC Securities Inc. now owns 671 shares of the company's stock worth $403,000 after acquiring an additional 119 shares during the period. Finally, nVerses Capital LLC increased its stake in shares of Chemed by 16.7% in the third quarter. nVerses Capital LLC now owns 700 shares of the company's stock worth $421,000 after acquiring an additional 100 shares during the period. Institutional investors and hedge funds own 95.85% of the company's stock.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on the stock. Royal Bank of Canada lowered their price target on shares of Chemed from $697.00 to $633.00 and set an "outperform" rating on the stock in a report on Tuesday, November 5th. StockNews.com raised shares of Chemed from a "hold" rating to a "buy" rating in a report on Saturday, November 30th.

Chemed Stock Performance

Shares of NYSE:CHE traded down $7.51 during midday trading on Friday, hitting $553.10. The company's stock had a trading volume of 41,026 shares, compared to its average volume of 94,463. The business's 50 day simple moving average is $542.34 and its 200 day simple moving average is $564.69. The company has a market cap of $8.32 billion, a P/E ratio of 27.95, a price-to-earnings-growth ratio of 2.16 and a beta of 0.48. Chemed Co. has a 12-month low of $512.12 and a 12-month high of $654.62.

Chemed Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 14th. Investors of record on Monday, February 24th will be given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 0.36%. Chemed's payout ratio is currently 10.11%.

Insider Buying and Selling

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $572.77, for a total transaction of $1,145,540.00. Following the completion of the sale, the chief executive officer now directly owns 101,735 shares in the company, valued at $58,270,755.95. This trade represents a 1.93 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Spencer S. Lee sold 732 shares of the firm's stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $575.62, for a total transaction of $421,353.84. Following the completion of the transaction, the executive vice president now directly owns 18,287 shares of the company's stock, valued at approximately $10,526,362.94. The trade was a 3.85 % decrease in their position. The disclosure for this sale can be found here. 3.32% of the stock is owned by company insiders.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.